New Delhi: Covaxin trial in the age group of 2-18 years has been cleared by the Drugs Controller General of India (DCGI) on Thursday. Bharat Biotech International Limited, Hyderabad had proposed to carry out the trial of the vaccine on the age group of 2-18 years.
In the phase Phase II/III clinical trial of the Covid vaccine will be carried out on 525 healthy volunteers by Bharat Biotech.
During the trial two vaccine doses will be injected by intramuscular route at day 0 and day 28. AIIMS (Delhi), AIIMS(Patna) and Meditrina Institute of Medical Sciences, Nagpur are the places for the trial.
Bhubaneswar: In a major initiative to support economically weaker families, 110 couples tied the knot…
Bhubaneswar: The Odisha government on Wednesday reviewed the functioning of fire and emergency response systems…
Bhubaneswar: The six-day Subhadra Shakti Leadership Summit, organised by the Mission Shakti Department, Government of…
Bhubaneswar: The Odisha Police on Thursday wrapped up its week-long mega exhibition on the Bharatiya…
Bhubaneswar: The Odisha government on Monday reviewed the availability and distribution of LPG, petrol and…
Bhubaneswar: A State-Level Workshop on “Role of Academic Institutions in Strengthening Social Behavioural Change Landscape…
